InOut Biome, LLC Gut microbiome sampling
Mechanical - Disposable
InOut is a novel non-invasive ingestible capsule used for gut Microbiome Sampling of localized areas and content for research and development.
The InOut delayed action and enteric action ingestible capsules are designed to be used in an ambulatory research and develop setting. The capsule is recovered from the stool, placed in a protective container, freeze or refrigerated until analyzed.
Fecal samples from stool are a complicated amalgamation of the total digestive processes and thwarts advances toward understanding the microbiome and its role in life, health, and disease.
InOut non-invasive methods captures localized upstream microbiota and content from the chyme instead of feces and can be repeated at will with one or more capsules at a time.
InOut Capsules can be used to determine microbiota communities and bodily fluid content before and after diets, during and after medical treatments, and its simplicity makes it a boon to the emerged DNA and microflora testing industry.
InOut is an unparalleled tool for medical diagnostics, treatment, and research. Consider immediate and differing delayed action capsules used alone or in series with one individual or any number of individuals repeatable at home or clinic. Obtain otherwise unavailable samples of microbe stains within their environment; sample virus mRNA before it degrades in the upper intestines. Metagenomic techniques can finally be used on localized material.
The idea for InOut was fostered by my need to sample microbiota and bodily fluid located in the small intestine and finding there was no practical way to do it. Present practice and methods are invasive and incomplete. No method exists for non-invasive localized gastrointestinal sampling. Incredibly the medical, clinical, and research professions are limited to samples provided by mouth swabs, anal swabs or stool, and endoscopic procedures. Our technology is answering this call one research level at a time.
The need is verified by market reports, research and medical publications, and National Science Foundation I-Corp market participation including over 100 interviews with global pharma medical conference attendees, physicians, gastroenterologists, researchers, testing laboratories, and animal health companies.
“All disease begins in the gut.”
―Hippocrates 460 BC ~ 370 BC
A novel, disruptive, medical device.
Assembling the puzzle to achieve commercial production of the InOut capsule has been completed. Product is available for research and development.
We wish to enter into strategic relationships with our technology. We have a robust IP position with a US patent, patent pending, and foreign patents pending.
If you are interested, we can provide a product overview and offer to enter into a NDA with your company to provide you with full details. Our objective is to secure an exclusive period of evaluation and dealing, something we are currently prepared to provide.